Inventor · disambiguated record
Catherine Llorens-Cortes
Also filed as: LLORENS-CORTES CATHERINE
6 granted patents·5 pending applications·26 citations·filing 1999–2021
76Inventor score
Files withQUANTUM GENOMICS5INST NAT SANTE RECH MED3INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE)1INSERM INSTITUT NATIONAL SANTE ET DE LA RECH MEDICALE1
Top patents by PatentIndex Score
11 records- 0173US11192907B2Aminopeptidase A inhibitors and pharmaceutical compositions comprising the sameQUANTUM GENOMICS·Filed 2019·Granted Dec 7, 2021·1 cites·13 claims
- 0270US7235687B2Derivatives of 4,4′-dithiobis-(3-aminobutane-1-sulfphonates) and compositions containing sameINST NAT SANTE RECH MED·Filed 2003·Granted Jun 26, 2007·5 cites·7 claims
- 0364US7582797B2Derivatives of 4,4′-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the sameINST NAT SANTE RECH MED·Filed 2004·Granted Sep 1, 2009·3 cites·16 claims
- 0458US2021206817A1Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin ReceptorINSERM INSTITUT NATIONAL SANTE ET DE LA RECH MEDICALE·Filed 2021·Application pending·0 cites
- 0556US6340708B1Pharmaceutical composition comprising at least one aminopeptidase A inhibitorINST NAT SANTE RECH MED·Filed 1999·Granted Jan 22, 2002·17 cites·14 claims
- 0649US2023233492A1Pharmaceutical combination comprising a brain aminopeptidase a inhibitor, a diuretic and a blocker of the systemic renin-angiotensin systemQUANTUM GENOMICS·Filed 2021·Application pending·0 cites
- 0746US11345658B2Compounds and compositions comprising the same for treating hypertension or heart failureQUANTUM GENOMICS·Filed 2020·Granted May 31, 2022·0 cites·18 claims
- 0844US2021309677A1Novel aminophosphinic derivatives as aminopeptidase a inhibitorsQUANTUM GENOMICS·Filed 2019·Application pending·0 cites
- 0940US10959938B2Combination of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agentQUANTUM GENOMICS·Filed 2012·Granted Mar 30, 2021·0 cites·4 claims
- 1038US2017355734A1Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin ReceptorINSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE)·Filed 2015·Application pending·0 cites
- 1138US2002061840A1Tripeptide compounds useful as selective inhibitors of aminopeptidase A and corresponding pharmaceutical compositionsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Catherine Llorens-Cortes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →